Adjuvant gemcitabine in case of carcinoma of pancreas. A case report
Medical Channel. 2006; 12 (3): 57-58
in English
| IMEMR
| ID: emr-79052
ABSTRACT
This report describes a case of a 53 year old man who presented with a diagnosis of carcinoma head of pancreas, and initially underwent surgery. Since carcinoma of pancreas has a high recurrence rate even after surgery, the patient was offered Gemcitabine [1000mg/m2, weekly for 7 weeks, then 1 week of rest followed by once weekly for 3 weeks, then rest week every 4 weeks]. He received 16 doses of gemcitabine. There was absolutely no grade 3 or 4 toxicity nor any delays, reductions or omission of doses. Post treatment CT scans showed no evidence of recurrence and patient is in good health 15 months post chemotherapy
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Tomography, X-Ray Computed
/
Chemotherapy, Adjuvant
/
Deoxycytidine
Type of study:
Case report
Limits:
Humans
/
Male
Language:
English
Journal:
Med. Channel
Year:
2006
Similar
MEDLINE
...
LILACS
LIS